Stallergenes Greer is a leading global biopharmaceutical company specialising in allergen immunotherapy for human and veterinary use. Its activities span the full value chain, from product development and commercialisation to allergy diagnosis and treatment. Backed by more than 120 years of expertise and innovation, the company’s products reach patients in 46 countries worldwide. Our vision: Leading innovative patient care to enable long-lasting allergy relief. An award winner in Switzerland's Best Managed Companies 2026. Link to our terms and conditions: https://www.stallergenesgreer.com/terms-and-conditions
Looking for a particular Stallergenes Greer employee's phone or email?
Stallergenes Greer Questions
The Stallergenes Greer annual revenue was $397 million in 2026.
Andreas Amrein is the Chief Executive Officer and Chairman of the Board of Stallergenes Greer.
869 people are employed at Stallergenes Greer.
Top Stallergenes Greer Employees
-
Andreas Amrein
Chief Executive Officer and Chairman of the Board at Stallergenes Greer
Canton of Zug, Switzerland35+ -
Elena Rizova
Chief Medical Officer at Stallergenes Greer
Zürich, ZH, CH21 -
13
-
1
Related Companies
